ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
bedger
|
1.6K |
485K |
14 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
1.6K
|
485K
|
14
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
bedger
|
1.6K |
485K |
6 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
1.6K
|
485K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
bedger
|
24K |
11M |
29 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
24K
|
11M
|
29
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
bedger
|
24K |
11M |
42 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
24K
|
11M
|
42
|
|
ASX - By Stock
|
ASM |
Re:
Ann: Results of Entitlement Offer
|
|
bedger
|
23 |
5.8K |
4 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
23
|
5.8K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
BIO International Convention
|
|
bedger
|
49 |
15K |
15 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
49
|
15K
|
15
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
bedger
|
285 |
44K |
5 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
285
|
44K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Stem Cell Therapy advancements
|
|
bedger
|
458 |
151K |
16 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
458
|
151K
|
16
|
|
ASX - By Stock
|
CYP |
Re:
Ann: CYP Presents at Major International Cell Therapy Conference
|
|
bedger
|
20 |
3.9K |
4 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
20
|
3.9K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Present at Clinical Trials at the Summit Meeting
|
|
bedger
|
14 |
2.7K |
2 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
14
|
2.7K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: CYP Presents at Major International Cell Therapy Conference
|
|
bedger
|
20 |
3.9K |
2 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
20
|
3.9K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: CYP Presents at Major International Cell Therapy Conference
|
|
bedger
|
20 |
3.9K |
7 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
20
|
3.9K
|
7
|
|
ASX - By Stock
|
HAS |
Re:
Ann: Renounceable Rights Issue to Support Yangibana Development
|
|
bedger
|
71 |
36K |
3 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
71
|
36K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Present at Clinical Trials at the Summit Meeting
|
|
bedger
|
14 |
2.7K |
8 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
14
|
2.7K
|
8
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Present at Clinical Trials at the Summit Meeting
|
|
bedger
|
14 |
2.7K |
1 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
14
|
2.7K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
$2 PARTY
|
|
bedger
|
8.1K |
1.4M |
5 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
8.1K
|
1.4M
|
5
|
|
ASX - By Stock
|
HAS |
Re:
Ann: Renounceable Rights Issue to Support Yangibana Development
|
|
bedger
|
71 |
36K |
0 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
71
|
36K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
bedger
|
285 |
44K |
9 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
285
|
44K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
BIO International Convention
|
|
bedger
|
49 |
15K |
15 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
49
|
15K
|
15
|
|
ASX - By Stock
|
ZIP |
Re:
$2 PARTY
|
|
bedger
|
8.1K |
1.4M |
8 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
8.1K
|
1.4M
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Presentation to Bell Potter Conference
|
|
bedger
|
149 |
65K |
28 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
149
|
65K
|
28
|
|
ASX - By Stock
|
ZIP |
Re:
$2 PARTY
|
|
bedger
|
8.1K |
1.4M |
9 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
8.1K
|
1.4M
|
9
|
|
ASX - By Stock
|
ZIP |
Re:
$2 PARTY
|
|
bedger
|
8.1K |
1.4M |
6 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
8.1K
|
1.4M
|
6
|
|
ASX - By Stock
|
ZIP |
Re:
$2 PARTY
|
|
bedger
|
8.1K |
1.4M |
2 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
8.1K
|
1.4M
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
$2 PARTY
|
|
bedger
|
8.1K |
1.4M |
4 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
8.1K
|
1.4M
|
4
|
|
ASX - By Stock
|
ZIP |
Re:
$2 PARTY
|
|
bedger
|
8.1K |
1.4M |
5 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
8.1K
|
1.4M
|
5
|
|
ASX - By Stock
|
ZIP |
Re:
$2 PARTY
|
|
bedger
|
8.1K |
1.4M |
5 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
8.1K
|
1.4M
|
5
|
|
ASX - By Stock
|
ZIP |
Re:
$2 PARTY
|
|
bedger
|
8.1K |
1.4M |
8 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
8.1K
|
1.4M
|
8
|
|
ASX - By Stock
|
ZIP |
Re:
$2 PARTY
|
|
bedger
|
8.1K |
1.4M |
4 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
8.1K
|
1.4M
|
4
|
|
ASX - By Stock
|
ZIP |
Re:
$2 PARTY
|
|
bedger
|
8.1K |
1.4M |
6 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
8.1K
|
1.4M
|
6
|
|
ASX - By Stock
|
ZIP |
Re:
$2 PARTY
|
|
bedger
|
8.1K |
1.4M |
9 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
8.1K
|
1.4M
|
9
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
bedger
|
285 |
44K |
3 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
285
|
44K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
bedger
|
285 |
44K |
6 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
285
|
44K
|
6
|
|
ASX - By Stock
|
OSX |
Re:
News: OSX Osteopore Raises A$2.9M From Entitlement Offer
|
|
bedger
|
86 |
25K |
0 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
86
|
25K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
bedger
|
1.6K |
485K |
7 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
1.6K
|
485K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
bedger
|
285 |
44K |
5 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
285
|
44K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
bedger
|
1.6K |
485K |
7 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
1.6K
|
485K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
bedger
|
285 |
44K |
4 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
285
|
44K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
bedger
|
526 |
165K |
5 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
526
|
165K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
bedger
|
526 |
165K |
5 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
526
|
165K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
bedger
|
285 |
44K |
8 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
285
|
44K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
bedger
|
285 |
44K |
1 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
285
|
44K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
bedger
|
285 |
44K |
4 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
285
|
44K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
bedger
|
285 |
44K |
3 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
285
|
44K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
bedger
|
285 |
44K |
5 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
285
|
44K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
bedger
|
285 |
44K |
7 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
285
|
44K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
bedger
|
873 |
334K |
8 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
873
|
334K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
bedger
|
873 |
334K |
6 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
873
|
334K
|
6
|
|
ASX - By Stock
|
HAS |
Re:
Ann: Hastings Organisational Restructure
|
|
bedger
|
28 |
16K |
2 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
28
|
16K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
bedger
|
17K |
6.7M |
13 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
17K
|
6.7M
|
13
|
|